Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HP 13C-Pyruvate +/- 13C,15N-Urea MRI in Prostate Cancer Patients Undergoing Radiation Therapy
NCT06391034Phase 2Recruiting
- Start
- Sep 2024
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hyperpolarized 13C-pyruvate in prostate cancer (PCa). Started Sep 2024; status: recruiting.
02
Drugs
hyperpolarized 13C-pyruvate
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT06391034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06391034.